Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Peter David Bloch Insider Profile
4 Followers
Peter David Bloch, Director at InnoCan Pharma, holds 0.00 shares in InnoCan Pharma (Ticker: INNPF). Most recently, Peter David Bloch Sold $72,222 shares of InnoCan Pharma on Nov 02, 2024 for an estimated value of 15.96K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+10.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Peter David Bloch does not currently own shares as a corporate insider.
A breakdown of Peter David Bloch's holdings
Insider Roles
Director
Roles that Peter David Bloch holds in companies
Most Profitable Insider Trade
The most profitable trade made by Peter David Bloch
Peter David Bloch's Trading History
List of latest transactions for each holding click on a transaction to see Peter David Bloch's performance on stock
You May Also Like
Peter David Bloch insider profile FAQ
What is the percentage of profitable transactions made by Peter David Bloch?
The percentage of profitable transactions made by Peter David Bloch is 50%.
What is the average return per transaction made by Peter David Bloch?
The average return per transaction made by Peter David Bloch is 10.00%.
What stocks does Peter David Bloch hold?
Peter David Bloch holds: INNPF stocks.
What was Peter David Bloch’s latest transaction?
Peter David Bloch latest transaction was an Informative Sell of $15.96K.
What was Peter David Bloch's most profitable transaction?
Peter David Bloch’s most profitable transaction was an Informative Sell of INNPF stock on September 24, 2024. The return on the trade was 31.50%.
What is Peter David Bloch's role in InnoCan Pharma?
Peter David Bloch's role in InnoCan Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.